Cargando…
The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model
BACKGROUND: An ideal animal model has always been the key to research the pathogenesis and treatment of adolescent idiopathic scoliosis (AIS), while available methods have obvious disadvantages. The deficiency of melatonin has been proved relating to AIS. In this research, we intended to apply Luzin...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379722/ https://www.ncbi.nlm.nih.gov/pubmed/28376758 http://dx.doi.org/10.1186/s12891-017-1500-x |
_version_ | 1782519663550267392 |
---|---|
author | Yang, Shuo Zheng, Chaojun Jiang, Jianyuan Lu, Feizhou Xia, Xinlei Zhu, Wei Jin, Xiang Ma, Xiaosheng |
author_facet | Yang, Shuo Zheng, Chaojun Jiang, Jianyuan Lu, Feizhou Xia, Xinlei Zhu, Wei Jin, Xiang Ma, Xiaosheng |
author_sort | Yang, Shuo |
collection | PubMed |
description | BACKGROUND: An ideal animal model has always been the key to research the pathogenesis and treatment of adolescent idiopathic scoliosis (AIS), while available methods have obvious disadvantages. The deficiency of melatonin has been proved relating to AIS. In this research, we intended to apply Luzindole, the melatonin antagonist, in bipedal rat model, for the block of combination of melatonin and its receptor, to inhibit the melatonin effect, and then to understand whether this method can effectively improve the scoliosis rate of bipedal rat model, and investigate the role of melatonin in scoliosis. To investigate the feasibility of improving the success rate of bipedal rat scoliosis model via intraperitoneal injection of melatonin antagonist (Luzindole). METHODS: A total of 60 3-weeks-old Sprague-Dawley rats were included in this study, and were divided into 3 groups (A, B and C). Each group included 20 rats. Osteotomy of the bilateral proximal humerus and proximal tailbone was performed in group A and group B; intraperitoneal injection of Luzindole (0.2 mg/kg) was performed in group A and group C. X-rays were taken before the surgery, 1 month after the surgery, 3 months after the surgery, and 6 months after the surgery, to calculate the Cobb’s angle of the spine (>10° was considered scoliosis). The weight of every rat was also measured at the same time. Rats were euthanized 6 months after surgery to determine the calmodulin level in thrombocytes. RESULTS: The rate of scoliosis in group A (14/20) was significantly higher than those in group B (6/20) and group C (0/20) (P < 0.05). The differences in the weights of the 3 groups were non-significant; as were differences in the calmodulin level in thrombocytes. CONCLUSION: The application of the melatonin antagonist of Luzindole can improve the success rate of the bipedal rat scoliosis model. Meanwhile, this study indicates that a decreased melatonin level is not the primary cause of scoliosis, but that it may increase the likelihood and severity of scoliosis. |
format | Online Article Text |
id | pubmed-5379722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53797222017-04-10 The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model Yang, Shuo Zheng, Chaojun Jiang, Jianyuan Lu, Feizhou Xia, Xinlei Zhu, Wei Jin, Xiang Ma, Xiaosheng BMC Musculoskelet Disord Research Article BACKGROUND: An ideal animal model has always been the key to research the pathogenesis and treatment of adolescent idiopathic scoliosis (AIS), while available methods have obvious disadvantages. The deficiency of melatonin has been proved relating to AIS. In this research, we intended to apply Luzindole, the melatonin antagonist, in bipedal rat model, for the block of combination of melatonin and its receptor, to inhibit the melatonin effect, and then to understand whether this method can effectively improve the scoliosis rate of bipedal rat model, and investigate the role of melatonin in scoliosis. To investigate the feasibility of improving the success rate of bipedal rat scoliosis model via intraperitoneal injection of melatonin antagonist (Luzindole). METHODS: A total of 60 3-weeks-old Sprague-Dawley rats were included in this study, and were divided into 3 groups (A, B and C). Each group included 20 rats. Osteotomy of the bilateral proximal humerus and proximal tailbone was performed in group A and group B; intraperitoneal injection of Luzindole (0.2 mg/kg) was performed in group A and group C. X-rays were taken before the surgery, 1 month after the surgery, 3 months after the surgery, and 6 months after the surgery, to calculate the Cobb’s angle of the spine (>10° was considered scoliosis). The weight of every rat was also measured at the same time. Rats were euthanized 6 months after surgery to determine the calmodulin level in thrombocytes. RESULTS: The rate of scoliosis in group A (14/20) was significantly higher than those in group B (6/20) and group C (0/20) (P < 0.05). The differences in the weights of the 3 groups were non-significant; as were differences in the calmodulin level in thrombocytes. CONCLUSION: The application of the melatonin antagonist of Luzindole can improve the success rate of the bipedal rat scoliosis model. Meanwhile, this study indicates that a decreased melatonin level is not the primary cause of scoliosis, but that it may increase the likelihood and severity of scoliosis. BioMed Central 2017-04-04 /pmc/articles/PMC5379722/ /pubmed/28376758 http://dx.doi.org/10.1186/s12891-017-1500-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Yang, Shuo Zheng, Chaojun Jiang, Jianyuan Lu, Feizhou Xia, Xinlei Zhu, Wei Jin, Xiang Ma, Xiaosheng The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model |
title | The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model |
title_full | The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model |
title_fullStr | The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model |
title_full_unstemmed | The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model |
title_short | The value of applying a melatonin antagonist (Luzindole) in improving the success rate of the bipedal rat scoliosis model |
title_sort | value of applying a melatonin antagonist (luzindole) in improving the success rate of the bipedal rat scoliosis model |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379722/ https://www.ncbi.nlm.nih.gov/pubmed/28376758 http://dx.doi.org/10.1186/s12891-017-1500-x |
work_keys_str_mv | AT yangshuo thevalueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel AT zhengchaojun thevalueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel AT jiangjianyuan thevalueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel AT lufeizhou thevalueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel AT xiaxinlei thevalueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel AT zhuwei thevalueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel AT jinxiang thevalueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel AT maxiaosheng thevalueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel AT yangshuo valueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel AT zhengchaojun valueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel AT jiangjianyuan valueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel AT lufeizhou valueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel AT xiaxinlei valueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel AT zhuwei valueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel AT jinxiang valueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel AT maxiaosheng valueofapplyingamelatoninantagonistluzindoleinimprovingthesuccessrateofthebipedalratscoliosismodel |